发明名称 |
Ocular allergy treatments using alcaftadine |
摘要 |
An ophthalmic composition that comprises alcaftidine, also known as 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5H-imidazo [2,1-b] [3] benzazepine-3-carboxaldehyde (Formula I) or a compound of Formula II. The compounds are antagonists for the histamine H4 receptor. The ophthalmic compositions are used in the treatment of a symptom of ocular allergy, in particular allergic conjunctivitis or ocular inflammation. |
申请公布号 |
NZ571690(A) |
申请公布日期 |
2011.09.30 |
申请号 |
NZ20070571690 |
申请日期 |
2007.03.26 |
申请人 |
VISTAKON PHARMACEUTICALS, LLC |
发明人 |
PARASRAMPURIA, JAGDISH;INGERMAN, AVNER;JANSSENS, FRANS;MEGENS, ANTON |
分类号 |
A61K31/55;A61P27/14 |
主分类号 |
A61K31/55 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|